

The Fidelity Blue Chip Growth ETF (FBCG) is upgraded to BUY, driven by renewed momentum in AI-linked blue chips and competitive valuations versus the Russell 1000 Growth. FBCG's concentrated portfolio, 57% tied to the AI CapEx cycle, offers high-beta exposure, with top holdings Nvidia, Apple, and Alphabet comprising 33.5%. I expect earnings growth, not multiple expansion, to drive returns, with a calculated target price of $73.86 implying ~15.5% upside from current levels.

Fidelity's actively managed large-cap growth ETF bets heavily on a handful of AI-linked giants, and that concentration cuts both ways. Here is what the portfolio actually owns and whether the active premium is worth paying.

On this episode of the “ETF of the Week” podcast, VettaFi's Head of Research, Todd Rosenbluth, discussed the Fidelity Blue Chip Growth ETF (FBCG) with Chuck Jaffe of Money Life. The pair discussed several topics related to the ETF, in order to give investors a deeper understanding of it.

On this episode of the “ETF of the Week” podcast, VettaFi's Head of Research, Todd Rosenbluth, discussed the Fidelity Blue Chip Growth ETF (FBCG) with Chuck Jaffe of Money Life. For more news, information, and analysis, visit VettaFi | ETF Trends.

Fidelity Blue Chip Growth ETF employs active, conviction-weighted stock selection, outperforming the Russell 1000 Growth Index over the past three years during market concentration phases. FBCG's portfolio is highly concentrated: over 60% in its top 10 holdings and 80-82% in tech, consumer discretionary, and communication services, amplifying both returns and volatility. While forward valuations in FBCG's core sectors appear reasonable, rising CAPEX and potential EPS disappointments pose significant downside risk if expected growth fails to materialize.

Markets continue to plow forward despite a crazy, volatile year in the news so far. Energy prices could be higher for the rest of the year, as the Strait of Hormuz crisis remains unsolved.

Rapid technological shifts and shifting interest rate expectations continue to define the current market environment. Amid the uncertainty, investors are looking for a reliable North Star to guide their growth allocations.

Fidelity Blue Chip Growth ETF (FBCG) is rated a buy, leveraging active management and exposure to high-growth technology and consumer cyclical sectors. FBCG outperformed major growth and momentum ETFs over the past three years, delivering a 162% price return and capitalizing on mispriced, fundamentally strong stocks. Current valuations are attractive after a recent 7% pullback, with technology and mega-cap holdings trading at multi-year low forward P/Es, positioning FBCG for recovery upside.